...
首页> 外文期刊>European Journal of Medicinal Plants >Clinical Evaluation of Efficacy of a Herbal Formulation Used in the Treatment of Malaria
【24h】

Clinical Evaluation of Efficacy of a Herbal Formulation Used in the Treatment of Malaria

机译:一种中药治疗疟疾疗效的临床评价

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Malaria is a public health problem and continues to be a major cause of morbidity and mortality in most tropical and subtropical countries. A rapid spread of malarial disease globally due to treatment failure has led to an urgent need for new effective antimalarials which medicinal plants have contributed to in medicine. The objective of this research is to determine the effectiveness of Mist Amen Fevermix which is a decoction of the stem bark of Morinda lucida and Parinari robusta in the treatment of uncomplicated malaria in humans, at the Tafo Government Hospital, Kumasi. Clinically established malaria in male and female patients aged, 15-60 years were treated with Mist Amen Fevermix, at the specified dose of 45 mls (0.45 g) three times daily for six days. A total of 50 patients were diagnosed with malaria disease. At the randomization visit, a detailed medical history was obtained and the patients underwent laboratory investigation was done at entry and after completing the study. All the 50 patients completed the study and there was a statistically significant difference between the mean levels of malaria parasite load recorded 28 indicating a significant effectiveness of Mist Amen Fevermix used by the patients. Parasitaemia clearance was 82.35% within the first three days in clients who responded positively to treatment. Results of the study suggest that Mist Amen Fevermix is an effective herbal antimalarial agent when used as specified by the manufacturer.
机译:疟疾是一个公共卫生问题,在大多数热带和亚热带国家,疟疾仍然是发病率和死亡率的主要原因。由于治疗失败,疟疾在全球范围内迅速传播,导致迫切需要新的有效抗疟药,药用植物已在医学上做出了贡献。这项研究的目的是在库马西塔佛政府医院,确定Moistda lucida和Parinarirobasta茎皮的水煎剂Mist Amen Fevermix的有效性,以治疗人类不复杂的疟疾。用Mist Amen Fevermix以45毫升(0.45克)的指定剂量每天3次,在15至60岁的男性和女性患者中临床确定的疟疾进行六天的治疗。共有50名患者被诊断出患有疟疾。在随机访视时,获得了详细的病史,并且在入院时和完成研究后对患者进行了实验室检查。所有50名患者均完成了研究,记录的平均疟疾寄生虫载量水平之间存在统计上的显着差异28,表明患者使用的Mist Amen Fevermix具有显着的有效性。对治疗反应积极的患者,头三天内寄生虫血症清除率为82.35%。研究结果表明,按照制造商的规定使用时,Mist Amen Fevermix是一种有效的草药抗疟剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号